
2 Day Virtual Africa Pharmaceutical Regulatory Affairs Training Course: Focus On Regulatory Requirements, Harmonization Initiatives, And The New SAHPRA Guidelines (Nov 4Th - Nov 5Th, 2025)
Dublin, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in Africa Training Course (Nov 4th - Nov 5th, 2025)" training has been added to ResearchAndMarkets's offering.
The value of the African pharmaceutical market is increasing and growth is expected to continue at a rapid pace. There are a number of distinct markets within the region, each with their own economic and regulatory characteristics. This event will explore the key areas of African regulatory affairs, including the new SAHPRA guidelines in South Africa, and will focus on practical aspects to assist with your regulatory activities. The expert speakers will share their knowledge of working in the region and the programme will include interactive discussion sessions to enable you to share experiences with other delegates.
Covering the key regions of Algeria, Botswana, Ethiopia, Ghana, Kenya, Malawi, Morocco, Mozambique, Namibia, Nigeria, South Africa, Tanzania, Tunisia, Uganda, Zambia, Zimbabwe.
Benefits of attending:
- Gain an overview of the regulatory requirements within African countries Understand requirements for company and product registration Learn practical information on compiling dossiers Discuss the new SAHPRA guidelines in South Africa Explore the harmonisation and cooperation initiatives in Africa, including the new African Medicines Agency
Participants will receive a course material folder containing comprehensive documentation provided by the speakers, which will be a valuable source of reference for the future.
Who Should Attend:
This event will be of particular interest to all those who need to learn about successful marketing authorisation applications and regulatory compliance in key African areas. It will be useful as both an introductory and a refresher course on recent developments.
Certifications:
- CPD: 12 hours for your records Certificate of completion
Key Topics Covered:
Day 1
Basic terms and environment
Harmonization initiatives
Regional presentations
- Each regional presentation will cover: The development of drug control
- The regulatory authorities Other influences
- How to determine an appropriate submission strategy A practical approach
- The regulatory authorities Other influences
- Regulations and guidelines New products and line extensions Labelling requirements Registration samples and certification/legalisation
- Contents and formats Hints on success/failure Specific country requirements
- Process Timelines
South Africa
- Influences and changes The new SAHPRA guidelines Latest regulatory processes adopted by SAHPRA Complementary and alternative medicines status Marketing code for the advertising of medicines
Namibia
Botswana
Zimbabwe
Zambia
Day 2
- Malawi Tanzania Kenya Uganda Nigeria Ghana Maghreb Countries - Algeria, Morocco, Tunisia
Speakers:
Salma Ismail
Twinz Regulatory Affairs Pharmacist Consultants
Salma Ismail is the CEO of Twinz Regulatory Affairs Pharmacist Consultants based in South Africa. Salma has over 20 years of experience within the Pharmaceutical Industry and in Regulatory Affairs, which includes understanding of legislation, technical issues, marketing regulations and training people within the pharmaceutical industry.
Her company is very involved with the submission of product applications for registration to regulatory authorities in South Africa and English speaking Africa for products from a diverse area that includes new chemical entities, generic molecules, biological medicines, complementary medicines including health supplements, medical devices and applications to regulatory authorities within the SADC region. Her company also deals with product life cycle maintenance by dealing with variations for submission to the authorities.
She is also involved in academia by lecturing on relevant pharmaceutical regulatory matters in prestigious universities in South Africa as well as training people from within the pharmaceutical industry environment. Salma is the former Chairperson of SAPRAA (Southern African Pharmaceutical Regulatory Affairs Association).
Makram Nehme
Parexel international
Makram Nehme is a Regional Regulatory Consultant having relevant experience with multiple multinationals including Parexel international, based in Lebanon. He has more than 10 years' experience in the Pharmaceutical and Medical Device Industry and is a Regulatory Expert covering the Middle East and North African markets. His experience includes negotiations with the Ministry of Health and Drug Agencies in the region, as well as training of key personnel and he has a proven record in regulatory submissions, analysis, product pricing and reimbursement across the MENA region.
For more information about this training visit
About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Pepeto Presale Exceeds $6.93 Million Staking And Exchange Demo Released
- Citadel Launches Suiball, The First Sui-Native Hardware Wallet
- Luminadata Unveils GAAP & SOX-Trained AI Agents Achieving 99.8% Reconciliation Accuracy
- Tradesta Becomes The First Perpetuals Exchange To Launch Equities On Avalanche
- Thinkmarkets Adds Synthetic Indices To Its Product Offering
- Edgen Launches Multi‐Agent Intelligence Upgrade To Unify Crypto And Equity Analysis
Comments
No comment